These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 11144703)

  • 1. Influence of beta-blockers on mortality in chronic heart failure.
    Hart SM
    Ann Pharmacother; 2000 Dec; 34(12):1440-51. PubMed ID: 11144703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
    Fowler MB
    Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers in heart failure. The 'new wave' of clinical trials.
    Krum H
    Drugs; 1999 Aug; 58(2):203-10. PubMed ID: 10473016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
    Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.
    Wikstrand J; Wedel H; Castagno D; McMurray JJ
    J Intern Med; 2014 Feb; 275(2):134-43. PubMed ID: 24118421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockers to reduce mortality in patients with systolic dysfunction: a meta-analysis.
    Lee S; Spencer A
    J Fam Pract; 2001 Jun; 50(6):499-504. PubMed ID: 11401736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of beta blockers in the treatment of heart failure.
    Chavey WE
    Am Fam Physician; 2000 Dec; 62(11):2453-62. PubMed ID: 11130231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocker benefit according to severity of heart failure.
    Bouzamondo A; Hulot JS; Sanchez P; Lechat P
    Eur J Heart Fail; 2003 Jun; 5(3):281-9. PubMed ID: 12798825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of beta-blockers in congestive heart failure.
    Sallach JA; Goldstein S
    Ann Med; 2003; 35(4):259-66. PubMed ID: 12846268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers in heart failure: how far have we progressed?
    Adams KF
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):7-15. PubMed ID: 19667603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
    Perreault S; de Denus S; White M; White-Guay B; Bouvier M; Dorais M; Dubé MP; Rouleau JL; Tardif JC; Jenna S; Haibe-Kains B; Leduc R; Deblois D
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):81-90. PubMed ID: 27859924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
    Fröhlich H; Torres L; Täger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
    Clin Res Cardiol; 2017 Sep; 106(9):711-721. PubMed ID: 28434020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of beta blockers on morbidity and mortality in heart failure.
    Jafri SM
    Heart Fail Rev; 2004 Apr; 9(2):115-21. PubMed ID: 15516859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistency of ss-blocker effect across various subgroups with heart failure: insights from the MERIT-HF trial.
    Wikstrand J; Ghali JK; Goldstein S
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):16-23. PubMed ID: 19667604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of beta-blockade on mortality rates in patients with congestive heart failure.
    Goldstein S; Gottlieb SS
    J Card Fail; 2000 Jun; 6(2 Suppl 1):15-24. PubMed ID: 10908094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of beta blockers in heart failure: clinical studies].
    Cobelli F
    Ital Heart J Suppl; 2000 Aug; 1(8):996-1002. PubMed ID: 10993005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carvedilol versus other beta-blockers in heart failure.
    Doggrell SA
    Expert Opin Investig Drugs; 2001 May; 10(5):971-80. PubMed ID: 11322870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
    Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
    Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of beta-adrenergic blockade on survival of patients with chronic heart failure.
    Packer M
    Am J Cardiol; 1997 Dec; 80(11A):46L-54L. PubMed ID: 9412542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.